Shai Rosenstein, Anna Vaisman-Mentesh, Limor Levy, Aya Kigel, Yael Dror, Yariv Wine
{"title":"Production of F(ab′)2 from Monoclonal and Polyclonal Antibodies","authors":"Shai Rosenstein, Anna Vaisman-Mentesh, Limor Levy, Aya Kigel, Yael Dror, Yariv Wine","doi":"10.1002/cpmb.119","DOIUrl":null,"url":null,"abstract":"Antibodies are widely used in therapeutic, diagnostic, and research applications, and antibody derivatives such as F(ab′)2 fragments are used when only a particular antibody region is required. F(ab′)2 can be produced through antibody engineering, but some applications require F(ab′)2 produced from an original formulated antibody or directly from a polyclonal antibody pool. The cysteine protease immunoglobulin‐degrading enzyme (IdeS) from Streptococcus pyogenes digests immunoglobulin G (IgG) specifically and efficiently to produce F(ab′)2. Here we detail the production and purification of recombinant IdeS; its utilization to digest monoclonal or polyclonal antibodies to F(ab′)2 fragments; and F(ab′)2 purification through consecutive affinity chromatography steps. The resultant F(ab′)2 exhibit high purity, retain antigen‐binding functionality, and are readily utilizable in various downstream applications. © 2020 by John Wiley & Sons, Inc.","PeriodicalId":10734,"journal":{"name":"Current Protocols in Molecular Biology","volume":"131 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2020-04-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1002/cpmb.119","citationCount":"2","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current Protocols in Molecular Biology","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/cpmb.119","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"Biochemistry, Genetics and Molecular Biology","Score":null,"Total":0}
引用次数: 2
单克隆抗体和多克隆抗体制备F(ab ')2
抗体广泛用于治疗、诊断和研究应用,抗体衍生物如F(ab ')2片段仅在需要特定抗体区域时使用。F(ab’)2可以通过抗体工程产生,但一些应用需要从原始配制的抗体或直接从多克隆抗体池中产生F(ab’)2。产化脓性链球菌的半胱氨酸蛋白酶免疫球蛋白降解酶(IdeS)特异高效地消化免疫球蛋白G (IgG)生成F(ab’)2。本文详细介绍了重组ide的生产和纯化;利用其消化F(ab’)2片段单克隆或多克隆抗体;F(ab’)2通过连续亲和层析纯化。所得的F(ab ')2具有高纯度,保留抗原结合功能,并且易于在各种下游应用中使用。©2020 by John Wiley &基本方案:使用IdeS从单克隆和多克隆抗体中生产和纯化F(ab’)2片段;备选方案:从人血清或分泌物中纯化多克隆抗原特异性F(ab’)2片段;支持方案:生产和纯化IdeS
本文章由计算机程序翻译,如有差异,请以英文原文为准。